Phase 2
Completed N=28
PRISM Race and Communication Pilot RCT
Discrimination, Racial · Communication · Chronic Illness · Bias, Racial
Source: ClinicalTrials.gov NCT04915079 ↗
Enrolled (actual)
28
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcomePrimary: 10-item Connor-Davidson Resilience Scale (CD-RISC) — 0.67; 0 average of number of units on a scale
Summary
This is a pilot randomized trial of 60 patients to test feasibility, acceptability and efficacy of PRISM to improve resilience and facilitate improved patient-clinician communication in racially minorities patients with serious illness.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY 10-item Connor-Davidson Resilience Scale (CD-RISC) |
0.67; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Seriously ill adults with median life expectancy of two years or less (e.g. metastatic cancer or inoperable lung cancer, chronic obstructive pulmonary disease (COPD) with forced expiratory volume in 1 second (FEV1) 17)
- Hospitalized at either Harborview Medical Center or University of Washington Medical Center-Montlake
- At least 18 years of age
- English-speaking
- No cognitive impairment precluding completion of surveys or participation in the PRISM sessions
Exclusion Criteria
- Younger than 18 years of age
- Non-English speaking
- Ccgnitive impairment that would preclude completion of surveys and participation in the PRISM sessions.
Data sourced from ClinicalTrials.gov (NCT04915079). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.